MX2007005708A - Virus del sindrome reproductor y respiratorio porcino mutante. - Google Patents

Virus del sindrome reproductor y respiratorio porcino mutante.

Info

Publication number
MX2007005708A
MX2007005708A MX2007005708A MX2007005708A MX2007005708A MX 2007005708 A MX2007005708 A MX 2007005708A MX 2007005708 A MX2007005708 A MX 2007005708A MX 2007005708 A MX2007005708 A MX 2007005708A MX 2007005708 A MX2007005708 A MX 2007005708A
Authority
MX
Mexico
Prior art keywords
respiratory syndrome
syndrome virus
porcine reproductive
mutant porcine
mutant
Prior art date
Application number
MX2007005708A
Other languages
English (en)
Inventor
Dogwan Yoo
Changhee Lee
Jay Gregory Calvert
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MX2007005708A publication Critical patent/MX2007005708A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2770/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invencion proporciona un virus del PRRS geneticamente modificado y polinucleotidos que lo codifican, tambien se proporcionan vacunas que comprenden el virus y polinucleotidos geneticamente modificados.
MX2007005708A 2004-11-11 2005-11-02 Virus del sindrome reproductor y respiratorio porcino mutante. MX2007005708A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62676704P 2004-11-11 2004-11-11
PCT/IB2005/003366 WO2006051396A1 (en) 2004-11-11 2005-11-02 Mutant porcine reproductive and respiratory syndrome virus

Publications (1)

Publication Number Publication Date
MX2007005708A true MX2007005708A (es) 2007-07-09

Family

ID=36061457

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007005708A MX2007005708A (es) 2004-11-11 2005-11-02 Virus del sindrome reproductor y respiratorio porcino mutante.

Country Status (16)

Country Link
US (1) US7879337B2 (es)
EP (1) EP1812573A1 (es)
JP (1) JP2008519594A (es)
KR (1) KR20070064666A (es)
CN (1) CN101056982A (es)
AR (1) AR051487A1 (es)
AU (1) AU2005303510B2 (es)
BR (1) BRPI0517745A (es)
CA (1) CA2586153C (es)
IL (1) IL182976A0 (es)
MX (1) MX2007005708A (es)
NO (1) NO20072578L (es)
RU (1) RU2007117510A (es)
TW (1) TW200636067A (es)
WO (1) WO2006051396A1 (es)
ZA (1) ZA200703762B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404253B2 (en) * 2006-12-28 2013-03-26 Newport Laboratories, Inc. Modified live (JMSO strain) Haemophilus parasuis vaccine
ME02271B (me) * 2011-02-17 2016-02-20 Boehringer Ingelheim Vetmedica Gmbh Novi evropski prrsv soj
WO2013163337A1 (en) * 2012-04-24 2013-10-31 The Ohio State University Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ513289A (en) 1998-12-22 2003-04-29 Pfizer Prod Inc Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof
US7132106B2 (en) 1998-12-22 2006-11-07 Pfizer Inc. Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
CA2370372C (en) 1999-04-22 2009-02-24 United States Department Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
WO2002095040A1 (en) * 2001-05-21 2002-11-28 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Delections in arterivirus replicons
US20020012670A1 (en) * 2000-01-26 2002-01-31 Knut Elbers Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
US6841364B2 (en) * 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
EP1438969A1 (en) 2003-01-14 2004-07-21 Universiteit Utrecht Arterivirus marker vaccine

Also Published As

Publication number Publication date
AU2005303510B2 (en) 2011-02-03
TW200636067A (en) 2006-10-16
ZA200703762B (en) 2008-09-25
EP1812573A1 (en) 2007-08-01
CA2586153A1 (en) 2006-05-18
CN101056982A (zh) 2007-10-17
WO2006051396A1 (en) 2006-05-18
RU2007117510A (ru) 2008-11-20
NO20072578L (no) 2007-08-02
AR051487A1 (es) 2007-01-17
US7879337B2 (en) 2011-02-01
AU2005303510A1 (en) 2006-05-18
IL182976A0 (en) 2007-08-19
KR20070064666A (ko) 2007-06-21
JP2008519594A (ja) 2008-06-12
CA2586153C (en) 2012-04-03
BRPI0517745A (pt) 2008-10-21
US20090004221A1 (en) 2009-01-01

Similar Documents

Publication Publication Date Title
TW200641126A (en) N protein mutants of porcine reproductive and respiratory syndrome virus
PL1951882T3 (pl) Kwasy nukleinowe kodujące szczepionkę przeciwko wirusowi wywołującemu zespół zaburzeń reprodukcyjnych i oddechowych u świń
EP1794329A4 (en) ISOLATES OF PORCINE RESPIRATORY DYSGENESIS SYNDROME (SDRP), AND METHODS OF USE
FR20C1016I1 (es)
IL175885A0 (en) Monovalent antibody fragments useful as therapeutics
SG165155A1 (en) Novel flavivirus antigens
SG156666A1 (en) Vaccines against japanese encephalitis virus and west nile virus
TW200745334A (en) Compositions and methods for producing a composition
LU92747I2 (fr) Virus de la diarrhée bovine atténué 1 (bvdv-1)
UA95778C2 (ru) Вирусы репродуктивно-респираторного синдрома свиней, их инфекционные клоны и мутанты и способы применения
WO2006082406A3 (en) Human antibodies and proteins
GEP20104956B (en) Compounds for inhibiting hepatitis c viral replication and use thereof
CO5700790A2 (es) Composiciones de vacuna que comprenden una interleucina 18 y sistema de adyuvante de saponina
WO2006091824A3 (en) Peptides for detection of antibody to porcine reproductive respiratory syndrome virus
PE20142330A1 (es) Vacuna de peptido ch3 de ige
DK1949913T3 (da) Immunstimulatorisk kombination til profylakserne og behandlingen af hepatitis C
ZA200210230B (en) Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine.
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
WO2003078604A3 (en) Tobacco rattle virus vectors and related compositions and methods
TW200619228A (en) Immunogenic compositions of staphylococcus epidermidis polypeptide antigens
MX2007005708A (es) Virus del sindrome reproductor y respiratorio porcino mutante.
AU2003213168A8 (en) Immunogenic hbc chimer particles stabilized with an n-terminal cysteine
UA89660C2 (ru) Мутанты n-протеина вируса репродуктивного и респираторного синдрома свиней
WO2007127372A3 (en) Genetic adjuvants for viral vaccines
WO2004041842A3 (en) Epitopes of hepatitis c virus